Wexford Capital

Sailfish is a yield-focused royalty company. Sailfish owns the TZ Royalty, which is a 3.5% royalty on revenues derived from the sale of gold on Eldorado Gold Corp.’s advanced stage Tocantinzinho gold project, and also holds a gold stream agreement on the San Albino gold project in Northern Nicaragua.

Shape Memory Medical Inc, based in Santa Clara, California, is a medical device company focused on developing innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. Founded to commercialize cutting-edge medical devices that utilize Shape Memory Polymer (SMP) materials, the company has introduced the first FDA-cleared device employing this technology within the vascular sector. This advancement allows physicians to enhance patient care through improved treatment options. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Bonterra Resources Inc. is a Canadian gold exploration company focused on the acquisition, exploration, and evaluation of mineral properties primarily in the province of Quebec. Incorporated in 2007 and headquartered in Val-d'Or, the company has established a significant land position of approximately 35,000 hectares within the Urban Barry Camp, situated in the mining-friendly Abitibi Greenstone Belt. Bonterra's key projects include the Gladiator Deposit, the Moroy Deposit, and the Barry Deposit. Notably, it operates the only permitted gold mill in the region, facilitating its exploration and mining activities. The company's operations encompass both mineral exploration and mining site care and maintenance, positioning it as a significant player in the Canadian gold sector.

Viseon, Inc. is a medical device company based in Irvine, California, focused on developing innovative technologies for Minimally Invasive Spine Surgery (MISS). Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has created the Voyant technology, which serves as a single-use disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical procedures by projecting the operative field onto a high-definition flat panel display, accessible both in the operating room and remotely. Viseon has rapidly advanced its product development, building a portfolio of devices aimed at improving clinical outcomes in spine surgery. The company holds 13 patents to protect its intellectual property and has formed a Scientific Advisory Board comprised of leading physicians in the field. Initial human-use studies are scheduled to commence soon, following successful pre-clinical trials.

AZTherapies, Inc. is a biopharmaceutical company based in Boston, Massachusetts, focused on discovering and developing innovative therapies for neurodegenerative diseases, including Alzheimer's, stroke, ALS, and Parkinson's. Founded in 2011, the company aims to fundamentally alter the progression of these diseases, improving cognitive function and quality of life for the aging population. Its lead candidate, ALZT-OP1, employs a multi-modal approach that targets neuroinflammation, recognized as a significant contributor to neurodegeneration. AZTherapies is currently conducting the Phase 3 COGNITE trial for early Alzheimer's disease, which is fully enrolled. In addition to its lead program, the company is advancing treatments for post-ischemic stroke cognitive impairment and ALS, addressing a critical need for effective therapies in these areas.

Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.

Viseon, Inc. is a medical device company based in Irvine, California, focused on developing innovative technologies for Minimally Invasive Spine Surgery (MISS). Established in 2017 as a spin-out from Rebound Therapeutics Corporation, Viseon has created the Voyant technology, which serves as a single-use disposable alternative to traditional surgical microscopes, endoscopes, and loupes. This technology enhances surgical procedures by projecting the operative field onto a high-definition flat panel display, accessible both in the operating room and remotely. Viseon has rapidly advanced its product development, building a portfolio of devices aimed at improving clinical outcomes in spine surgery. The company holds 13 patents to protect its intellectual property and has formed a Scientific Advisory Board comprised of leading physicians in the field. Initial human-use studies are scheduled to commence soon, following successful pre-clinical trials.

Shape Memory Medical Inc, based in Santa Clara, California, is a medical device company focused on developing innovative therapeutic solutions for the peripheral vascular, cardiovascular, and neurovascular markets. Founded to commercialize cutting-edge medical devices that utilize Shape Memory Polymer (SMP) materials, the company has introduced the first FDA-cleared device employing this technology within the vascular sector. This advancement allows physicians to enhance patient care through improved treatment options. The team at Shape Memory Medical possesses significant expertise in SMP foam technology and the commercialization of medical devices, positioning the company as a leader in its field.

Rebound Therapeutics Corp. focuses on developing single-use, disposable medical devices aimed at enhancing access, imaging, and illumination during minimally invasive surgical procedures. Established in 2015 and headquartered in Irvine, California, the company has rapidly advanced its product line, offering innovative devices designed to improve procedural and clinical outcomes across various surgical specialties, including neurosurgery, spine and orthopedic surgery, and general abdominal surgery. Rebound has assembled a distinguished Scientific Advisory Board of leading minimally invasive surgery physicians and has filed 14 patents to protect its innovative technologies. The company has also completed several pre-clinical studies, paving the way for initial human-use trials that are set to begin soon. As of September 2019, Rebound Therapeutics operates as a subsidiary of Integra LifeSciences Holdings Corporation.

ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Dig Inn is a restaurant inspired by the seasons and the act of cooking. Classic recipes with lots of vegetables, expertly prepared, and sourced mindfully from farmers and producers we know and trust. Whether you’re looking for whole grains, naturally-raised meats, or fresh veggies, we’ve got a bowl with your name on it.

OptiScan Biomedical Corporation specializes in developing advanced glucose monitoring systems for use in intensive care units. The company is known for its OptiScanner 5000, an automated bedside platform that provides precise plasma-based glucose measurements using spectroscopy technology, eliminating the need for calibration. This system enables healthcare providers to monitor and respond to changes in glucose levels for critically ill patients effectively. Founded in 1994 and headquartered in Hayward, California, OptiScan Biomedical faced financial challenges, filing for Chapter 11 bankruptcy in June 2020 and subsequently converting to Chapter 7 bankruptcy in November 2020.

Sophono, Inc. is a medical device manufacturer based in Boulder, Colorado, specializing in implantable magnetic bone conduction hearing devices. Founded in 2009, the company focuses on providing solutions for individuals with conductive hearing loss, mixed hearing loss, and single-sided deafness. Its flagship product, the Alpha 2 MPO, offers an abutment-free design that allows for under-the-skin implantation, enhancing user comfort and convenience. Sophono's devices are designed for patients experiencing severe to profound hearing impairment, and they are distributed through clinics. As of 2015, Sophono operates as a subsidiary of Medtronic plc.

Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Ellipse Technologies is a privately-held medical device company based in California, specializing in the development of innovative implantable remote control technology for spinal and orthopedic applications. The company focuses on creating non-invasively adjustable implants designed to address a wide range of conditions, including spinal deformities and orthopedic trauma. Its flagship products include the MAGEC MAGnetic Expansion Control System, which employs a minimally-invasive method to correct spinal deformities through remote adjustment using an external magnetic field, and the PRECICE System, which utilizes adjustable intramedullary rods or bone plates to manage long-bone abnormalities resulting from fractures. Ellipse is dedicated to advancing treatment options in the fields of spinal and orthopedic medicine.

Reverse Medical is a commercial-stage medical device company dedicated to developing innovative solutions for revascularizing patients suffering from acute ischemic strokes. The company specializes in creating embolic protection systems aimed at treating neurovascular disorders, with a strong emphasis on endovascular management of acute stroke conditions. Through its advanced medical technologies, Reverse Medical seeks to improve patient outcomes and enhance the overall standard of care in the treatment of stroke.

International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries — designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.

Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.

Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.

Interventional Spine, Inc. specializes in the design, development, production, and distribution of implantable devices tailored for spine surgery, addressing the needs of patients, surgeons, and hospitals globally. Founded in 2000 and headquartered in Irvine, California, the company has a strong focus on developing innovative solutions for the treatment of osteoporotic fractures, utilizing its proprietary CLASP® technology that enhances fracture fixation in both normal and osteoporotic bone. Interventional Spine offers a range of products, including the Opticage expandable interbody fusion device and the PERPOS PLS System for facet fixation, along with devices aimed at the podiatric and orthopedic trauma markets. The company has successfully implanted thousands of orthopedic trauma products, significantly improving surgical outcomes through enhanced pullout resistance and precise positioning. Interventional Spine operates as a subsidiary of DePuy Synthes, further expanding its reach in the medical device industry.

Epiphany Biosciences is developing both therapeutic products and diagnostic technologies that treat or prevent the spread of pathogenic viruses. Epiphany Biosciences is a privately-held company located in San Francisco, CA. To support its mission, Epiphany has assembled a world-class team of virologists, clinicians, and drug development experts with extensive pharmaceutical business experience to lead the company forward.

ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

As the vanguard of distributed energy control, Encorp leverages the power of its advanced Gold Box™ to harness diverse forms of generation in today's New Energy Economy. Their energy-tech offerings and grid interconnection expertise advance energy savings, security and efficiency for federal, institutional and commercial installations. Their technologies transform the electric grid into a system that is cleaner, more cost effective, efficient, flexible, reliable, resilient and responsive. Encorp's elegant software and hardware seamlessly integrate a variety of distributed power resources, such as engine-generator sets, microturbines, fuel cells, combined heat and power (CHP or cogeneration), and energy storage devices. These power resources are critical in the operation of any enterprise that demands high-quality, reliable power at reasonable and predictable costs.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.